摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

pyridinium.tetrakis(pentafluorophenyl)borate | 146874-32-0

中文名称
——
中文别名
——
英文名称
pyridinium.tetrakis(pentafluorophenyl)borate
英文别名
Pyridin-1-ium;tetrakis(2,3,4,5,6-pentafluorophenyl)boranuide
pyridinium.tetrakis(pentafluorophenyl)borate化学式
CAS
146874-32-0
化学式
C5H5N*C24BF20*H
mdl
——
分子量
759.152
InChiKey
ITHXDEKMLPVMDE-UHFFFAOYSA-O
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    6.35
  • 重原子数:
    51
  • 可旋转键数:
    4
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    14.1
  • 氢给体数:
    1
  • 氢受体数:
    21

反应信息

  • 作为反应物:
    描述:
    pyridinium.tetrakis(pentafluorophenyl)borate 、 以 氘代四氢呋喃 为溶剂, 反应 144.0h, 生成
    参考文献:
    名称:
    氢加(钳)IrI(CO)配合物:立体和电子因素的重要性
    摘要:
    (POCOP)Ir-I(CO) [POCOP = kappa(3)-C6H3-2,6-(OPR2)(2) for R = Bu-t, Pr-i] and (PCP)Ir-I(CO) [PCP = kappa(3)-C6H3-2,6-(CH2PR2)(2) for R = Bu-t and Pr-i] complexes can add hydrogen via two distinct pathways. When R = Bu-t, (POCOP)Ir(CO) and (PCP)Ir(CO) complexes only add hydrogen via a proton-catalyzed pathway due to steric effects, yielding trans-dihydride complexes. For R = Pr-i, both systems oxidatively add hydrogen to give cis-dihydride complexes which thermally isomerize to more thermodynamically favorable trans-dihydride species, consistent with previous reports. Proton-catalyzed hydrogen addition pathways are also observed for both Pr-i-substituted (pincer)Ir(CO) complexes. (PCP)Ir(CO) complexes add hydrogen under milder conditions than the analogous POCOP species. Intermediate hydrido-pyridine Ir(III) carbonyl complexes from the proton-catalyzed pathway have been synthesized and characterized. This is the first report of a series of complexes shown to add hydrogen via concerted oxidative addition or a proton-catalyzed pathway to the same iridium center.
    DOI:
    10.1021/acs.organomet.6b00598
点击查看最新优质反应信息

文献信息

  • Cyclopentadienyl Complexes of Ir<sup>III</sup> for Attempted C−D Bond Activation
    作者:Robert D. Robinson、Werner Kaminsky、Jeremiah J. Scepaniak
    DOI:10.1002/ejic.202300369
    日期:2023.9.25
    Abstract

    The complexes Cp(MeIm)IrI2 and CpMe4(MeIm)IrCl2 have been prepared and subsequently methylated to form Cp(MeIm)IrMe2 and CpMe4(MeIm)IrMe2 (Cp=η5‐C5H5, CpMe45‐C5HMe4, MeIm=1,3‐dimethylimidazol‐2‐ylidene). We attempted unsuccessfully to use the dimethyl complexes to study C−D bond activation via methyl‐group abstraction. Protonation with one equivalent of a weak acid, such as 2,6‐dimethylpyridinium chloride, affords methane and IrIII methyl chloride complexes. 1H‐NMR experiments show addition of pyridinium [BArF20] (BArF20=[B(C6F5)4]) to the dimethyl species forms [Cp(MeIm)IrMe(py)]+[BArF20] (py=pyridine) or [CpMe4(MeIm)IrMe(py)]+[BArF20] respectively, alongside methane, while use of the [BArF20] salts of more bulky 2,6‐dimethylpyridinium and 2,6‐di‐tert‐butylpyridinium gave an intractable mixture. Likewise, the generation of 16 e species [CpMe4(MeIm)IrMe]+[BArF20] or [Cp(MeIm)IrMe]+[BarF20] at low temperature using 2,6‐dimethylpyridinium or 2,6‐di‐tert‐butylpyridinium in thawing C6D6 or toluene‐d8 formed an intractable mixture and did not lead to C−D bond activation. X‐ray structures of several IrIII complexes show similar sterics as that found for the previously reported Cp* analogue.

    摘要制备了 Cp(MeIm)IrI2 和 CpMe4(MeIm)IrCl2 复合物,随后将其甲基化,形成 Cp(MeIm)IrMe2 和 CpMe4(MeIm)IrMe2 (Cp=η5-C5H5,CpMe4=η5-C5HMe4,MeIm=1,3-二甲基咪唑-2-亚基)。我们曾尝试用二甲基络合物来研究通过甲基基团萃取活化 C-D 键,但未成功。用一种等效的弱酸(如 2,6-二甲基氯化吡啶)进行质子化,可得到甲烷和 IrIII 甲基氯化物络合物。1H-NMR 实验显示,将吡啶鎓 [BArF20]- (BArF20=[B(C6F5)4]-)加入二甲基络合物后,分别形成 [Cp(MeIm)IrMe(py)]+[BArF20]-(py=吡啶)或 [CpMe4(MeIm)IrMe(py)]+[BArF20]-、而使用体积更大的 2,6-二甲基吡啶鎓和 2,6-二叔丁基吡啶鎓的[BArF20]-盐,则会产生难以处理的混合物。同样,在解冻的 C6D6 或甲苯-d8 中使用 2,6-二甲基吡啶鎓或 2,6-二叔丁基吡啶鎓在低温下生成 16 个 e- 物种 [CpMe4(MeIm)IrMe]+[BArF20]- 或 [Cp(MeIm)IrMe]+[BarF20]- 时,也会形成难溶混合物,并且不会导致 C-D 键活化。几种 IrIII 复合物的 X 射线结构显示出与先前报告的 Cp* 类似物类似的立体结构。
  • Hydrogen Addition to (pincer)Ir<sup>I</sup>(CO) Complexes: The Importance of Steric and Electronic Factors
    作者:Jonathan M. Goldberg、Sophia D. T. Cherry、Louise M. Guard、Werner Kaminsky、Karen I. Goldberg、D. Michael Heinekey
    DOI:10.1021/acs.organomet.6b00598
    日期:2016.10.24
    (POCOP)Ir-I(CO) [POCOP = kappa(3)-C6H3-2,6-(OPR2)(2) for R = Bu-t, Pr-i] and (PCP)Ir-I(CO) [PCP = kappa(3)-C6H3-2,6-(CH2PR2)(2) for R = Bu-t and Pr-i] complexes can add hydrogen via two distinct pathways. When R = Bu-t, (POCOP)Ir(CO) and (PCP)Ir(CO) complexes only add hydrogen via a proton-catalyzed pathway due to steric effects, yielding trans-dihydride complexes. For R = Pr-i, both systems oxidatively add hydrogen to give cis-dihydride complexes which thermally isomerize to more thermodynamically favorable trans-dihydride species, consistent with previous reports. Proton-catalyzed hydrogen addition pathways are also observed for both Pr-i-substituted (pincer)Ir(CO) complexes. (PCP)Ir(CO) complexes add hydrogen under milder conditions than the analogous POCOP species. Intermediate hydrido-pyridine Ir(III) carbonyl complexes from the proton-catalyzed pathway have been synthesized and characterized. This is the first report of a series of complexes shown to add hydrogen via concerted oxidative addition or a proton-catalyzed pathway to the same iridium center.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐